Latest Insider Transactions at Akero Therapeutics, Inc. (AKRO)
This section provides a real-time view of insider transactions for Akero Therapeutics, Inc. (AKRO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Akero Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Akero Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Timothy Rolph Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,064
+0.58%
|
$20,216
$19.94 P/Share
|
|
Jun 11
2024
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,825
-3.64%
|
$62,150
$22.64 P/Share
|
|
Jun 11
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,516
-0.99%
|
$55,352
$22.64 P/Share
|
|
Jun 11
2024
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,380
-1.3%
|
$52,360
$22.64 P/Share
|
|
Jun 11
2024
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,831
-5.7%
|
$62,282
$22.64 P/Share
|
|
Jun 11
2024
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
7,894
-1.34%
|
$173,668
$22.64 P/Share
|
|
Jun 11
2024
|
Patrick Lamy Senior VP, Commercial Strategy |
SELL
Open market or private sale
|
Direct |
569
-2.97%
|
$12,518
$22.64 P/Share
|
|
Jun 03
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.94%
|
$95,000
$19.29 P/Share
|
|
May 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.9%
|
$100,000
$20.15 P/Share
|
|
Apr 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
400
-0.15%
|
$10,000
$25.02 P/Share
|
|
Apr 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,600
-1.71%
|
$110,400
$24.33 P/Share
|
|
Mar 13
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
651
-0.24%
|
$18,228
$28.33 P/Share
|
|
Mar 13
2024
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
1,969
-0.33%
|
$55,132
$28.33 P/Share
|
|
Mar 13
2024
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
724
-1.44%
|
$20,272
$28.33 P/Share
|
|
Mar 13
2024
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
723
-0.92%
|
$20,244
$28.33 P/Share
|
|
Mar 13
2024
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
619
-0.34%
|
$17,332
$28.33 P/Share
|
|
Mar 04
2024
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
20,646
-20.84%
|
$722,610
$35.49 P/Share
|
|
Mar 04
2024
|
Catriona Yale Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,646
+9.93%
|
$268,398
$13.73 P/Share
|
|
Mar 04
2024
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
75,000
-1.96%
|
$2,475,000
$33.99 P/Share
|
|
Mar 04
2024
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+5.35%
|
$1,350,000
$18.55 P/Share
|
|
Mar 01
2024
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,321
+23.65%
|
$0
$0.62 P/Share
|
|
Jan 02
2024
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+6.34%
|
$0
$0.62 P/Share
|
|
Dec 27
2023
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,414
-2.84%
|
$129,936
$24.0 P/Share
|
|
Dec 27
2023
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,414
+2.76%
|
$32,484
$6.36 P/Share
|
|
Dec 14
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
597
-0.76%
|
$11,940
$20.76 P/Share
|
|
Dec 14
2023
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
611
-1.2%
|
$12,220
$20.76 P/Share
|
|
Dec 14
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
1,628
-0.29%
|
$32,560
$20.76 P/Share
|
|
Dec 14
2023
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
543
-0.29%
|
$10,860
$20.76 P/Share
|
|
Dec 14
2023
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
514
-0.28%
|
$10,280
$20.76 P/Share
|
|
Dec 11
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
7,405
-1.32%
|
$148,100
$20.02 P/Share
|
|
Dec 11
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,405
+1.31%
|
$44,430
$6.36 P/Share
|
|
Dec 08
2023
|
Jonathan Young Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,497
+14.9%
|
-
|
|
Dec 08
2023
|
William Richard White Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,497
+38.94%
|
-
|
|
Dec 08
2023
|
Patrick Lamy Senior VP, Commercial Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
18,570
+50.0%
|
-
|
|
Dec 08
2023
|
Timothy Rolph Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,497
+15.07%
|
-
|
|
Dec 08
2023
|
Catriona Yale Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,497
+29.28%
|
-
|
|
Dec 08
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
100,000
+6.07%
|
$1,900,000
$19.83 P/Share
|
|
Dec 08
2023
|
Andrew Cheng President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
91,541
+14.21%
|
-
|
|
Dec 08
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
12,873
-2.72%
|
$257,460
$20.01 P/Share
|
|
Dec 08
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,873
+2.64%
|
$77,238
$6.36 P/Share
|
|
Dec 07
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
6,700
-1.43%
|
$134,000
$20.02 P/Share
|
|
Dec 07
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,700
+1.41%
|
$40,200
$6.36 P/Share
|
|
Dec 01
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
50,000
+6.67%
|
$800,000
$16.99 P/Share
|
|
Nov 30
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
50,000
+7.14%
|
$800,000
$16.9 P/Share
|
|
Nov 17
2023
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-16.38%
|
$420,000
$14.68 P/Share
|
|
Oct 02
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.05%
|
$1,200,000
$48.35 P/Share
|
|
Oct 02
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.89%
|
$150,000
$6.36 P/Share
|
|
Oct 02
2023
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
490
-0.27%
|
$24,990
$51.1 P/Share
|
|
Oct 02
2023
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
490
+0.27%
|
$10,290
$21.1 P/Share
|
|
Sep 21
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.03%
|
$240,000
$48.11 P/Share
|